The American Heart Association's 2026 Scientific Sessions will feature major late-breaking trials on cardiovascular prevention, stroke, arrhythmias, cardiometabolic disease, gene editing and artificial intelligence.
Experts from the University of Michigan Health Frankel Cardiovascular Center are available before and during the meeting to provide independent analysis and context on several anticipated presentations, including ZEUS, HORIZON, CTX310 and emerging AI-enabled cardiovascular technolog
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.